We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
-5.88%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$72.5M
AUM Growth
+$2.3M
Cap. Flow
+$515K
Cap. Flow %
0.71%
Top 10 Hldgs %
42.25%
Holding
101
New
4
Increased
56
Reduced
16
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$346K
2
LLY icon
Eli Lilly
LLY
+$273K
3
WDAY icon
Workday
WDAY
+$223K
4
COST icon
Costco
COST
+$205K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$198K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$365K
2
UNP icon
Union Pacific
UNP
+$246K
3
COHR icon
Coherent
COHR
+$235K
4
FDX icon
FedEx
FDX
+$232K
5
ENB icon
Enbridge
ENB
+$214K

Sector Composition

Rank Sector Weight
1 Technology 43.31%
2 Healthcare 15.22%
3 Consumer Discretionary 9.06%
4 Financials 6.72%
5 Communication Services 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
76
Oracle
ORCL
$420B
$289K 0.4%
4,732
+952
+25% +$69.7K
VZ icon
77
Verizon
VZ
$194B
$289K 0.4%
7,626
+665
+10% +$29.6K
OKE icon
78
Oneok
OKE
$55.2B
$283K 0.39%
5,531
+357
+7% +$21.2K
U icon
79
Unity
U
$18.7B
$277K 0.38%
8,708
+725
+9% +$29.8K
LITE icon
80
Lumentum
LITE
$69B
$272K 0.38%
3,974
– –
ABNB icon
81
Airbnb
ABNB
$104B
$269K 0.37%
2,561
– –
F icon
82
Ford
F
$55.8B
$264K 0.36%
23,572
+18
+0.1% +$252
CVX icon
83
Chevron
CVX
$367B
$254K 0.35%
1,774
+98
+6% +$14.9K
STWD icon
84
Starwood Property Trust
STWD
$6B
$253K 0.35%
13,888
-4,927
-26% -$112K
STZ icon
85
Constellation Brands
STZ
$23.2B
$248K 0.34%
1,079
– –
VEEV icon
86
Veeva Systems
VEEV
$37.1B
$248K 0.34%
1,510
– –
KO icon
87
Coca-Cola
KO
$374B
$237K 0.33%
4,239
+106
+3% +$6.59K
ADP icon
88
Automatic Data Processing
ADP
$108B
$231K 0.32%
1,022
+1
+0.1% +$236
BAC icon
89
Bank of America
BAC
$439B
$230K 0.32%
7,628
+250
+3% +$8.36K
EA
90
DELISTED
Electronic Arts
EA
$223K 0.31%
1,930
-90
-4% -$11.4K
REGN icon
91
Regeneron Pharmaceuticals
REGN
$80.1B
$216K 0.3%
+315
New +$198K
WDAY icon
92
Workday
WDAY
$44.1B
$216K 0.3%
+1,425
New +$223K
BHVN
93
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$204K 0.28%
1,355
-2,460
-64% -$365K
CRUS icon
94
Cirrus Logic
CRUS
$6.24B
$203K 0.28%
2,960
-55
-2% -$4.32K
SOFI icon
95
SoFi Technologies
SOFI
$23.5B
$142K 0.2%
29,250
-600
-2% -$3.8K
COHR icon
96
Coherent
COHR
$74.4B
– –
-4,620
Closed -$235K
ENB icon
97
Enbridge
ENB
$112B
– –
-5,078
Closed -$214K
FDX icon
98
FedEx
FDX
$75B
– –
-1,024
Closed -$232K
IVE icon
99
iShares S&P 500 Value ETF
IVE
$49.8B
– –
-1,495
Closed -$205K
NWL icon
100
Newell Brands
NWL
$2.54B
– –
-10,972
Closed -$208K
1 2 3
4
5

Similar funds

VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
CMBA
C.M. Bidwell & Associates Honolulu, Hawaii $214M AUM 18.82% 1-Year Est. Return
IH
IES Holdings Houston, Texas $214M AUM

KRS Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, KRS Capital Management held 101 positions worth $72.5M, up 3.3% from $70.2M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

KRS Capital Management's Q3 2022 filing shows 4 new, 56 increased, 16 reduced and 6 closed positions. Its largest new stake was Pfizer: 7,115 shares worth $311K. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $365K.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 48% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • KRS Capital Management's largest Q3 2022 buy was Pfizer: 7,115 shares worth $311K.
  • KRS Capital Management added most to Eli Lilly in Q3 2022, an estimated $273K increase.
  • KRS Capital Management's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $365K.
  • KRS Capital Management fully exited Union Pacific in Q3 2022, selling an estimated $246K.
  • KRS Capital Management's ten largest holdings make up 42% of its $72.5M portfolio in Q3 2022.
  • KRS Capital Management opened 4 new positions and closed 6 in Q3 2022.
  • KRS Capital Management's portfolio value rose 3.3% quarter-over-quarter to $72.5M.

Based on KRS Capital Management's 13F filing for Q3 2022, filed 21 Oct 2022.